Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents
Abdallah Hamzé, Mouâd Alami, Olivier Provot
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112110-112110
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Novel Tetrazole Derivatives Targeting Tubulin Endowed with Antiproliferative Activity against Glioblastoma Cells
Laura Gallego‐Yerga, Andrea Jazmín Chiliquinga, Rafael Peláez
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11093-11093
Open Access | Times Cited: 3
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells
Shu Wang, Azizah M. Malebari, Thomas F. Greene, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1000-1000
Open Access | Times Cited: 3
The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer Therapy
Jing Nie, Huina Wu, Yepeng Luan, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 480-490
Closed Access | Times Cited: 3
Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties
Syed Nasir Abbas Bukhari, Mohamed Y. Zakaria, Muhammad Usman Munir, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 679-679
Open Access | Times Cited: 5
Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line
Myriam González, María Ovejero-Sánchez, Alba Vicente‐Blázquez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1029-1047
Open Access | Times Cited: 7
Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity
Xu Liu, Xiaojing Pang, Yuan Liu, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 4047-4047
Open Access | Times Cited: 7
Light-driven photoswitching of quinazoline analogues of combretastatin A-4 as an effective approach for targeting skin cancer cells
Alexander M. Scherbakov, R. Yu. Balakhonov, Diana I. Salnikova, et al.
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 35, pp. 7670-7677
Closed Access | Times Cited: 7
Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents
Raquel Álvarez, Laura Aramburu, Consuelo Gajate, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112933-112933
Open Access | Times Cited: 6
Design, synthesis, and biological evaluation of tetrahydroisoquinoline stilbene derivatives as potential antitumor candidates
Bo Li, Jie Wang, Ming Yuan, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 2, pp. 364-379
Open Access | Times Cited: 3
Photostability and Antiproliferative Activity of Furan Analogues of Combretastatin A-4
Alexander M. Scherbakov, A. V. Zakharov, Ekaterina I. Mikhaevich, et al.
Chemical Research in Toxicology (2022) Vol. 35, Iss. 11, pp. 2014-2024
Closed Access | Times Cited: 3
Design, synthesis, and bioevaluation of diarylpyrimidine derivatives as novel microtubule destabilizers
Yutao Xiu, Yujing Zhang, Shanbo Yang, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access
Recent advances of selenized tubulin inhibitors in cancer therapy
Yang Zhao, Long Yan, Yuan Xu
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130037-130037
Closed Access
Synthesis and Antitumor Activity of Novel Terephthalamide Derivatives
Yifei Gu, Caiju Wu, Siqi Wang, et al.
Chinese Journal of Organic Chemistry (2024) Vol. 44, Iss. 11, pp. 3497-3497
Closed Access
Controlling Reactivity and Selectivity in the Mizoroki-Heck Reaction: High Throughput Evaluation of 1,5-Diaza-3,7-diphosphacyclooctane Ligands
Eric S. Isbrandt, Devon E. Chapple, Nguyễn Thiên Phúc Từ, et al.
(2023)
Open Access | Times Cited: 1
Synthesis and structure–activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization
Ruiqiang Zhang, Hualong Mo, Yanyan Ma, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 40, pp. 127968-127968
Closed Access | Times Cited: 3
Synthesis and Anticancer Properties of Oxazepines Related to Azaisoerianin and IsoCoQuines
Ilhem Khelifi, Shannon Pecnard, Guillaume Bernadat, et al.
ChemMedChem (2020) Vol. 15, Iss. 16, pp. 1571-1578
Open Access | Times Cited: 2
Combretastatin Derivatives as Tubulin Inhibitors: A Fascinating Journey from Nature to Drug Discovery Strategies
Alessandra Ammazzalorso, Trond Vidar Hansen
BENTHAM SCIENCE PUBLISHERS eBooks (2022), pp. 112-144
Closed Access | Times Cited: 1
Pyrazoles, isoxazoles, and 1,2,3-triazoles as analogs of the natural cytostatic combretastatin A-4: efficient routes of synthesis, tubulin inhibition, and cytotoxicity
R. K. Kostin, Aleksander S. Marshavin
Chemistry of Heterocyclic Compounds (2021) Vol. 57, Iss. 11, pp. 1061-1072
Closed Access | Times Cited: 1
Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds
Xiaohelaiti Haimiti, Wu Wen-Ping, Yiting Gao, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 14, pp. 1644-1651
Closed Access
Other plant metabolites
Denise Jean‐Louis, Samson Amos, David Simpson
Elsevier eBooks (2023), pp. 295-309
Closed Access
Previous Page - Page 2

Scroll to top